Oncology Institute (TOI) Stock Forecast & Price Target

$0.33

+0.02 (+6.52%)

(As of 09/30/2024 ET)

Oncology Institute - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 1 Analyst Ratings

Sell
0

Hold
0

Buy
1

Based on 1 Wall Street analysts who have issued ratings for Oncology Institute in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for TOI.

Consensus Price Target

$2.50
664.76% Upside

According to the 1 analysts' twelve-month price targets for Oncology Institute, the average price target is $2.50. The highest price target for TOI is $2.50, while the lowest price target for TOI is $2.50. The average price target represents a forecasted upside of 664.76% from the current price of $0.33.

Get the Latest News and Ratings for TOI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oncology Institute and its competitors.

TOI Analyst Ratings Over Time

Type	Current Forecast 10/2/23 to 10/1/24	1 Month Ago 9/2/23 to 9/1/24	3 Months Ago 7/4/23 to 7/3/24	1 Year Ago 10/2/22 to 10/2/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$2.50	$2.50	$2.50	$2.00
Forecasted Upside	664.76% Upside	592.90% Upside	412.40% Upside	41.84% Upside
Consensus Rating	Buy	Buy	Buy	Buy

My grim warning about AI stocks (Ad)

Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.

TOI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TOI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oncology Institute Stock vs. The Competition

Type	Oncology Institute	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.78	2.50
Consensus Rating	Buy	Moderate Buy	Hold
Predicted Upside	664.76% Upside	823.01% Upside	6.15% Upside
News Sentiment Rating	Neutral News See Recent TOI News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
2/26/2024	Jefferies Financial Group 2 of 5 stars		Initiated Coverage	Buy	$2.50	+35.87%
6/16/2023	Guggenheim 3 of 5 stars		Lower Target		$3.00 ➝ $2.00	+231.18%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 07:20 AM ET.

TOI Forecast - Frequently Asked Questions

: According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for Oncology Institute is $2.50, with a high forecast of $2.50 and a low forecast of $2.50.
: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oncology Institute in the last twelve months. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" TOI shares.
: According to analysts, Oncology Institute's stock has a predicted upside of 664.76% based on their 12-month stock forecasts.
: Analysts like Oncology Institute more than other "medical" companies. The consensus rating for Oncology Institute is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how TOI compares to other companies.